Nitinotes, developer of EndoZip ™, a fully automated endoscopic suturing system aimed at treating obesity, today announced that clinical research on the EndoZip ™ system will be presented at upcoming ...
Nitinotes has commenced its US investigational device exemption (IDE) Endoscopic Automated Sleeve Evaluation (EASE) clinical trial, with the first patient treated using the EndoZip automated suturing ...
CAESAREA, Israel, Nov. 6, 2025 /PRNewswire/ -- Nitinotes Ltd., a medical device company transforming the treatment of obesity, today announced it has received CE Mark approval for the EndoZip ™ System ...
CAESAREA, Israel, April 23, 2026 /PRNewswire/ -- Nitinotes Ltd., a medical technology company with the first CE-marked automated suturing system designed for endoscopic sleeve gastroplasty (ESG), ...
In 2016 more than 650 million adults worldwide were classified as obese with a body mass index (BMI) of 30 or higher, according to the World Health Organization, and a 2017 study found that in Israel ...
Automated Endoscopic Approach Evaluated for Patients with Obesity, Hypertension, and Type 2 Diabetes The interim results reflect data from one of several participating clinical sites in a multicenter ...
CAESAREA, Israel, April 2, 2025 /PRNewswire/ -- Nitinotes, developer of EndoZip(TM), a fully automated endoscopic suturing system aimed at treating obesity, today announced that clinical research on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results